October 07, 2021
According to the report titled ‘U.S. Dialysis Market Size By Type (Hemodialysis, Peritoneal Dialysis), By Product & Service, By End-use (In-center Dialysis, Home Dialysis), COVID-19 Impact Analysis, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2021 – 2027’, available with MarketStudyReport, the U.S. dialysis market is expected to grow considerably during the forecast period 2021-2027.
The major driver for growth in the U.S. dialysis market is the rising prevalence of kidney failure amongst the population. Surging instances of chronic diseases, like diabetes and blood pressure, lead to kidney failure, which further supports the demand for dialysis.
Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/4202310/
Notably, the process of dialysis aids in the artificial filtering of blood after kidney failure by removing waste and water from the blood.
During the Covid-19 outbreak, patients who tested positive for the new coronavirus infection experienced acute kidney injury (AKI) and other renal problems. As a result, demand for dialysis has increased across the United States post the pandemic, positively swaying the business dynamics.
Based on type, the U.S. dialysis market is segmented into hemodialysis, and peritoneal dialysis. In 2020, the peritoneal dialysis segment held a market share of 10.5%, and is projected to expand at a significant rate between 2021 and 2027. Peritoneal dialysis has gained popularity in recent years as a result of technical advances in dialysis machines.
As per the product & services spectrum, the market is categorized into consumables, equipment, and services. The equipment segment surpassed a valuation of USD 2 billion in 2020 and there is an expectation of rapid expansion over the assessment period.
In terms of end-use, the market is divided into two categories: in-center dialysis, and home dialysis. The in-center dialysis segment share is estimated to increase at a CAGR of 6% throughout the research period.
Regionally speaking, the U.S. dialysis market spans through East North Central, South Atlantic, West South Central, East South Central, North East, Pacific Central, West North Central, and the Mountain States. In 2020, West South Central accounted for 13.5% industry share and is projected to generate substantial revenue by the end of 2027.
The competitive landscape of the U.S. dialysis market includes companies like American Renal Associates Holdings Inc., U.S. Renal Care Inc., Baxter International Inc., Sanderling Renal Services LLC, Fresenius Medical Care AG & Co. KGaA, Medtronic plc, DaVita Inc., Nipro Corporation, Asahi Kasei Corporation, Toray Industries Inc., and B. Braun Melsungen AG among others.